insights_auto
Why is BOT down ၅.၅၆%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
၀.၀၁၇ A$
arrow_downward
-၅.၅၆%(-၀.၀၀၁၀၀) 1D
အောက် ၅, GMT+၁၁ ၁၆:၁၀:၀၈ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
၀.၀၂ A$
High
၀.၀၂ A$
Low
၀.၀၂ A$
Mkt. cap
၄.၂၃ ကုဋေ
Avg. vol.
၆.၄၁ သန်း
Volume
၀.၀၀
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
Open
၀.၀၂ A$
High
၀.၀၂ A$
Low
၀.၀၂ A$
Mkt. cap
၄.၂၃ ကုဋေ
Avg. vol.
၆.၄၁ သန်း
Volume
၀.၀၀
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၂၀ မိနစ်
Did New Science Board Just Shift BioCryst's (BCRX) Investment Narrative?
Stock Titan
·
ပြီးခဲ့သည့် ၃၉ မိနစ်
Five new hires’ options vest over four years, if they stay
Investing.com
·
ပြီးခဲ့သည့် ၅ မိနစ်
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.18%
Stocktwits
·
ပြီးခဲ့သည့် ၁ နာရီ
MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd